Navigation Links
Study Results Reveal Oral Growth Hormone Boosting Supplement May Be Capable of Producing the Same Benefits as Synthetic Growth Hormone Injections
Date:11/21/2013

NEW YORK, Nov. 21, 2013 /PRNewswire/ -- While human growth hormone (hGH) therapy has become a staple among the rich and famous thanks to its notoriety for purportedly being able to reduce wrinkles, tighten saggy skin, decrease body fat, increase lean muscle mass, boost energy, rev up sex drive, and make people look and feel decades — not years, but DECADES — younger, there has been a marked lack of clinical studies exploring these benefits. That's why a recent study on an oral growth hormone booster's effects on endurance garnered so much attention among experts attending the prestigious Obesity Week Conference held recently in Atlanta, Georgia.

The study revolved around SeroVital®, an hGH secretagogue that's been causing quite a stir at scientific conferences around the world ever since a group of some of the most renowned researchers in the world revealed that it was capable of increasing mean, serum (blood) growth hormone levels by 682%. This was headline news, because up until this point most felt the best way to increase hGH levels was through expensive prescription injections (costs can run as high as $1500 per month). In addition to their high cost, these synthetic hGH injections are extremely controversial, because some experts fear that introducing synthetic hGH into the body may upset the natural production of hGH.

"That's what makes SeroVital so different," says Dr. Amy Heaton, PhD, Director of Scientific Affairs for SanMedica International™, SeroVital's distributor. "Rather than introducing synthetic hGH into the body via injections, SeroVital increases the body's own, endogenous levels of human growth hormone by promoting pituitary health, the gland that manufactures hGH. SeroVital not only provides a more affordable way for people to raise their hGH levels, but does so in a clinically validated way that allows users to achieve this naturally and without the risks associated with injections."

And now SeroVital is making news again with the release of a study analyzing its effects on endurance. The results of this study showed that after two weeks of daily supplementation with this patented hGH secretagogue, not only was subjects' VO2max (the established measure of endurance) significantly increased, but numeric increases in both resting metabolic rate and estimated daily calorie expenditure were also seen.

"Increased measures of endurance are a well-established outcome of synthetic recombinant human growth hormone (rhGH) injections in adults," explains Dr. Heaton. "But our research on the SeroVital compound is so exciting because it's the first study of its kind to show that an oral growth hormone secretagogue may be capable of producing an expected benefit the same as that of synthetic hGH injections. And while the present study was not sufficiently powered to detect a significant change in mean resting metabolic rate and estimated daily calorie expenditure, these parameters showed increased values over baseline following the treatment period, evidencing the potential of the supplement to impart long-term fat burning effects."

The promise this research holds — especially because it doesn't require the administration of controversial synthetic hGH injections — could lead to an increased understanding of the ability of youthful growth hormone levels to impact excess body weight and fat mass, which is quickly becoming a major global health hazard. Dr. Heaton adds, "Further research in this area may provide insight to potential effects on body composition and weight regulation by the amino acid based hGH secretagogue. A larger multi-center study is being planned."

For more information about Obesity Week, visit www.ObesityWeek.com. To get the full details on SeroVital, visit www.SeroVital.com. You can purchase SeroVital directly from SanMedica International by calling 1-800-285-5192 or www.SeroVital.com. Use the promo code SERO43 at checkout and shipping is free.*

*Free standard shipping in the continental U.S. only.


'/>"/>
SOURCE SeroVital
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Irvine Center for Clinical Research Announces Open Enrollment for New Low Testosterone Study
2. Chicago Man Breathes Again Thanks to Northwestern Medicine Study
3. Phase IIb Study of Vanoxerine Shows Strong Safety and Statistically Significant Efficacy Signals for Treatment of Atrial Fibrillation
4. Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
5. Epizymes EPZ-5676 DOT1L Inhibitor Demonstrates Encouraging Initial Findings in an Ongoing Phase 1 Dose Escalation Study
6. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions OVA1 Test in Presurgical Detection of Early-Stage Ovarian Cancer
7. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions Ovarian Cancer Test, OVA1
8. ChanRx to Present Results of Phase IIb Study in Atrial Fibrillation at the 2013 American Heart Association Scientific Sessions
9. Isis Pharmaceuticals Earns $1.5M from the Advancement of the Phase 2 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy
10. Certifications, Presentation of Study Results and Earnings Releases - Research Report on Agilent, Mindray, Bard, Tornier, and Life Technologies
11. Revalesio Initiates Phase IIa Study of RNS60 in Multiple Sclerosis at University Hospital Zurich
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... , June 16, 2017  Exactly 50 years ago ... off what later became known as the San Francisco "Summer ... ) is unveiling two radical innovations in strategic market research ... This announcement marks the beginning of Northern Light,s "Summer of ... ...
(Date:6/12/2017)... , June 12, 2017 Kineta, Inc., a biotechnology ... Kineta Vice President of R&D and Head of ... Pandemic Preparedness for the Northwest and Beyond meeting ... on June 14, 2017 from 8:30-10:30 AM PDT at the ... Dr. Bedard will be joined by other ...
(Date:6/8/2017)... MAITLAND, Fla. , June 8, 2017  Less ... ransomware attack that hit more than 200,000 companies, including hospital ... is being heralded as one of the largest online ... technology in the healthcare market, it is imperative that ... can protect their data from this — and many ...
Breaking Medicine Technology:
(Date:6/23/2017)... , ... June 23, 2017 , ... Everybody has their ... while others prefer to read it, and some people don't like it at all. ... Here's what they found: , Erotic literature can give readers a taste of their ...
(Date:6/23/2017)... ... June 23, 2017 , ... 21 Middle East and South Asia Leaders Selected ... from government, business and civil society in 11 countries across the Middle East and ... in a transformative exchange of knowledge and ideas with the leading minds in their ...
(Date:6/23/2017)... ... 23, 2017 , ... Ulster University, Magee Campus in Northern Ireland is hosting ... pm to present to graduate students exciting new and innovative hope research based on ... by The Health Improvement Service of the Western Health & Social Care Trust (WHSCT) ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
Breaking Medicine News(10 mins):